Handelsinvest Investeringsforvaltning’s OptimizeRx OPRX Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-110,000	Closed	-$1.63M	–	108
2022 Q3	$1.63M	Hold	110,000	–	–	0.26%	87
2022 Q2	$3.01M	Hold	110,000	–	–	0.45%	77
2022 Q1	$4.15M	Buy	110,000 +10,000	+10%	+$443K	0.5%	76
2021 Q4	$6.21M	Sell	100,000 -10,000	-9%	-$758K	0.63%	67
2021 Q3	$9.41M	Hold	110,000	–	–	1.03%	37
2021 Q2	$6.81M	Hold	110,000	–	–	0.76%	51
2021 Q1	$5.36M	Sell	110,000 -10,000	-8%	-$482K	0.65%	58
2020 Q4	$3.74M	Buy	120,000 +40,000	+50%	+$980K	0.56%	73
2020 Q3	$1.67M	Buy	+80,000	New	+$1.37M	0.32%	84

Other funds holding OPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's OPRX Position: Q4 2022 in Review

Handelsinvest Investeringsforvaltning sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 110,000 shares — an estimated $1.63M sold.

Handelsinvest Investeringsforvaltning first reported a position in OPRX in Q3 2020 and held it in 9 quarters. The position peaked at $9.41M in Q3 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.

Handelsinvest Investeringsforvaltning reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 110,000 OptimizeRx shares in Q4 2022, an estimated $1.63M.
Handelsinvest Investeringsforvaltning first reported a position in OptimizeRx in Q3 2020 and held it in 9 quarters.
Handelsinvest Investeringsforvaltning's OptimizeRx position peaked at $9.41M in Q3 2021.
129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2022, filed 18 Jan 2023.